Photo Credit: wildpixel

Recent highlights in multiple sclerosis (MS) coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a sampling of recent research on these topics.

Evidence Over Time in the Diagnosis of MS

Demonstrating neurologic damage over time, referred to as dissemination in time (DIT), may not be required to diagnose multiple sclerosis (MS) in all patients, according to research published in Neurology.

To read more, click here.

Prodromal Features of Pediatric MS

A subset of common symptoms and diagnoses, including obesity, dizziness and giddiness, and visual disturbances, in the 5 years before a multiple sclerosis diagnosis in children hints at a potential prodromal phase of the condition.

To read more, click here.

Q&A: PREG-MS Registry

Maria K. Houtchens, MD, talked with Physician’s Weekly about the prospective multiple sclerosis (MS) pregnancy registry (PREG-MS) and its potential impacts on the care of women with MS who are considering pregnancy or who are already pregnant.

To read more, click here.

Q&A: PIRA & RAW as Markers of Neurodegeneration

Moogeh Baharnoori, MD, talked with Physician’s Weekly about findings that question the role of progression and worsening indices as markers of neurodegeneration in multiple sclerosis.

To read more, click here.